Orlistat NEW

Orlistat is a long-acting, potent and specific gastrointestinal lipase inhibitor. It inactivates the above two enzymes by forming a covalent bond with the active serine site of lipase in the stomach and small intestine. The inactivated enzyme cannot break down the fat in food into free fatty acids and glycerol that can be absorbed by the human body, thereby reducing fat intake and playing a role in weight loss. This product is suitable for long-term treatment of obese and overweight people, including those who have already developed risk factors related to obesity, in combination with a mild low-calorie diet. This product has the efficacy of long-term weight control (weight loss, weight maintenance and prevention of rebound). Taking orlistat can reduce the incidence of risk factors related to obesity and other obesity-related diseases, including hypercholesterolemia, type 2 diabetes, impaired glucose tolerance, hyperinsulinemia, hypertension, and can reduce the fat content in organs.